Evidence map›Paper›PMID 32081867›Full record

ArticleScientific reports2020

An integrated analysis of rare CNV and exome variation in Autism Spectrum Disorder using the Infinium PsychArray.

Elena Bacchelli, Cinzia Cameli, Marta Viggiano, Roberta Igliozzi, Alice Mancini, Raffaella Tancredi, Agatino Battaglia, Elena Maestrini

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Association and functional study ofWorld journal of psychiatry · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Role ofFrontiers in molecular neuroscience · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elena BacchelliDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. elena.bacchelli@unibo.it.ORCID http://orcid.org/0000-0001-8800-9568
Cinzia Cameli *Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Marta Viggiano *Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Roberta IgliozziIRCCS Stella Maris Foundation, Viale del Tirreno 331, 56128, Calambrone, Pisa, Italy.
Alice ManciniIRCCS Stella Maris Foundation, Viale del Tirreno 331, 56128, Calambrone, Pisa, Italy.
Raffaella TancrediIRCCS Stella Maris Foundation, Viale del Tirreno 331, 56128, Calambrone, Pisa, Italy.
Agatino BattagliaIRCCS Stella Maris Foundation, Viale del Tirreno 331, 56128, Calambrone, Pisa, Italy.
Elena MaestriniDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. elena.maestrini@unibo.it.ORCID http://orcid.org/0000-0001-5924-3179
Fondazione Stella Maris · ITUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental condition with a complex and heterogeneous genetic etiology. While a proportion of ASD risk is attributable to common variants, rare copy-number variants (CNVs) and protein-disrupting single-nucleotide variants (SNVs) have been shown to significantly contribute to ASD etiology. We analyzed a homogeneous cohort of 127 ASD Italian families genotyped with the Illumina PsychArray, to perform an integrated analysis of CNVs and SNVs and to assess their contribution to ASD risk. We observed a higher burden of rare CNVs, especially deletions, in ASD individuals versus unaffected controls. Furthermore, we identified a significant enrichment of rare CNVs intersecting ASD candidate genes reported in the SFARI database. Family-based analysis of rare SNVs genotyped by the PsychArray also indicated an increased transmission of rare SNV variants from heterozygous parents to probands, supporting a multigenic model of ASD risk with significant contributions of both variant types. Moreover, our study reinforced the evidence for a significant role of VPS13B, WWOX, CNTNAP2, RBFOX1, MACROD2, APBA2, PARK2, GPHN, and RNF113A genes in ASD susceptibility. Finally, we showed that the PsychArray, besides providing useful genotyping data in psychiatric disorders, is a valuable and cost-efficient tool for genic CNV detection, down to 10 kb.

Indexed as

DNA Copy Number VariationsExomeAutism Spectrum DisorderFamily HealthFemaleGene DeletionGene DuplicationGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHeterozygoteHumansItalyLinkage DisequilibriumMaleOligonucleotide Array Sequence Analysis

Identifiers

PMID32081867
PMCPMC7035424
OpenAlexW3008557426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.